Keryx Biopharmaceuticals (KERX) Jumps On Trial Results

September 23, 2009 9:44 AM EDT Send to a Friend
Shares of Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX) are 25% higher today after the companyh announced results of the Open Label ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login